RNF213 Variants and Collateral Vessels in Moyamoya Disease

Beijing Tiantan Hospital300 enrolled

Overview

The purpose of this study is to detect the association between RNF213 variants and collateral vessels in patients with moyamoya disease.

Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by the presence of occlusion which occurs at the internal carotid arteries and their main branches during the development of a basal collateral network. The ring finger 213 (RNF213) was identified as a strong susceptibility gene in patients with MMD in East Asia. The role of RNF213 variants in pathogenesis of MMD is still unclear. Specific "moyamoya vessels" correlate with the onset of stroke. The purpose of this study is to investigate the relationship between RNF213 variants and collateral vessels in patients with moyamoya disease, and provide potential pathogenesis of moyamoya disease.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Moyamoya Disease

Interventions

Identification of genetic variantsOTHER

Identification of genetic variants

Eligibility

Sex: ALLMin age: 4 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Written informed consent is obtained * Patients with age between 4-60 years * Cerebral digital subtraction contrast angiography (DSA) reveal severe stenosis or occlusion of the distal internal carotid or proximal middle and anterior cerebral arteries with prominent lenticulostriate 'moyamoya collaterals' Exclusion Criteria: * There are other vascular diseases, including systemic vasculitis, neurofibroma, meningitis, sickle cell disease, down's syndrome, and previous basilar radiotherapy * Patients with cardiogenic embolism, including a history of atrial fibrillation, valvular disease or cardiac valve replacement * Physical or subjective failure to cooperate with the examination or serious comorbid diseases

Locations (1)

Beijing Tiantan Hospital Capital Medical University

Beijing, Beijing Municipality, China

Outcomes

Primary Outcomes

Identification of RNF213 variants and different types of collateral vessels

Time frame: Baseline

Secondary Outcomes

Identification of serum biomarkers and different types of collateral vessels

Hcy, HDL, LDL, ApoA, ApoB et al.

Time frame: Baseline

Identification of clinical characteristics and different types of collateral vessels

Age, Gender, Clinical manifestations, Comorbidities, BMI et al.

Time frame: Baseline

Identification of RNF213 variants, serum biomarkers, clinical characteristics and different types of postoperative collateral vessels

Time frame: 6-12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.